for the main comparison.

Stopping long‐acting beta2‐agonists (LABA) compared with continuing inhaled corticosteroids (ICS) + LABA for children with well‐controlled asthma
Patient or population: children (aged 18 years or younger) whose asthma is well controlled on combination ICS + LABA Settings: outpatient Intervention: stopping LABA Comparison: continuing ICS + LABA
Outcomes	No of Participants (studies)	Comments
Exacerbations requiring systemic corticosteroids	0 (0)	No studies met the inclusion criteria for the review
Asthma control (validated scales)	0 (0)
Serious adverse events (all cause)	0 (0)
Quality of life (validated scales)	0 (0)
Exacerbations requiring hospitalisation or emergency department visit	0 (0)
Adverse events (all cause)	0 (0)
Withdrawals	0 (0)